NME2 and gastric cancer: In this study, the findings revealed that the transcription factor NME2 could suppress apoptosis of gastric cancer stem-like cells via promoting the expression of anti-apoptosis genes (RIPK1, STARD5, and LIMS1), indicating that NME2 was an anti-apoptosis transcription factor in gastric cancer stem cells.